Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Treatment
41 results:

  • 1. Evaluation of the predictive effects of trauma scoring systems in colorectal injuries.
    Altiok M; Tümer H; Sarıtaş AG
    Eur J Trauma Emerg Surg; 2024 Feb; 50(1):269-274. PubMed ID: 37555993
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Age With treatment-Related Adverse Events and Survival in Patients With Metastatic colorectal cancer.
    Meng L; Thapa R; Delgado MG; Gomez MF; Ji R; Knepper TC; Hubbard JM; Wang X; Permuth JB; Kim RD; Laber DA; Xie H
    JAMA Netw Open; 2023 Jun; 6(6):e2320035. PubMed ID: 37358854
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative Radiotherapy Decision-Tree for Rectal cancer Patients: A Real-World Analysis Based on the Swedish colorectal cancer Registry.
    Luo B; Fan C; Xie X; Loftås P; Sun XF
    Clin Colorectal Cancer; 2023 Sep; 22(3):280-290. PubMed ID: 37270356
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
    Lee TH; Jang BS; Chang JH; Kim E; Park JH; Chie EK
    Cancer Med; 2023 Jul; 12(14):15664-15675. PubMed ID: 37260182
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Robot-assisted TAMIS: a systematic review of feasibility and outcomes.
    Jakobsen PCH; Krarup PM; Jensen KK; Nordholm-Carstensen A
    Surg Endosc; 2023 May; 37(5):3398-3409. PubMed ID: 36707419
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
    Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
    Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
    Principe DR
    Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pan-cancer landscape of
    Kelly AD; Murugesan K; Kuang Z; Montesion M; Ross JS; Albacker LA; Huang RSP; Lin DI; Demirci U; Creeden J
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34815356
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of colorectal cancer Cells by Using the Proteomic Approach.
    Cheng KC; Kuo HC; Hsieh MC; Huang CY; Teng CC; Tung SY; Shen CH; Lee KF; Yang YL; Lee KC
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572494
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. miR-766-5p Targets Super-Enhancers by Downregulating cbp and BRD4.
    Gen Y; Muramatsu T; Inoue J; Inazawa J
    Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
    Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
    J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer.
    Song K; Cai H; Zheng H; Yang J; Jin L; Xiao H; Zhang J; Zhao Z; Li X; Zhao W; Li X
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33855351
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
    Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
    Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
    [No Abstract]    [Full Text] [Related]  

  • 14. Histone Acetyltransferase (HAT) P300/cbp Inhibitors Induce Synthetic Lethality in PTEN-Deficient colorectal cancer Cells through Destabilizing AKT.
    Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
    Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL.
    Zhang B; Chen D; Liu B; Dekker FJ; Quax WJ
    Biochem Pharmacol; 2020 May; 175():113914. PubMed ID: 32173363
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic capacities of cbp and p300 in locally advanced rectal cancer.
    Rühlmann F; Windhof-Jaidhauser IM; Menze C; Beißbarth T; Bohnenberger H; Ghadimi M; Dango S
    World J Surg Oncol; 2019 Dec; 17(1):224. PubMed ID: 31856851
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of colorectal cancer to 5-Fluorouracil.
    Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
    Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
    Xian D; Zhao Y
    J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/cbp signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.